Sort
40,608 grants matching “prostate cancer”
Molecular Biology, Regulation, And Biochemistry of UDP-glucuronosyltransferases.
$906,055Ida S Owens · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
San Antonio Center - Biomarkers for Prostate Cancer
$905,861Ian M Thompson · University Of Texas Hlth Science Center · U01 · FY2008 · CA
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy
$905,712Robert S Langer · Massachusetts Institute Of Technology · U54 · FY2014 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CARCINOGENESIS
$905,577University Of Minnesota Twin Cities · R01 · FY2000 · CA
Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer
$905,526Stephen B Kahl · Manzanita Pharmaceuticals, Inc. · R44 · FY2024 · CA
INTEGRATED ULTRASONIC SYSTEMS FOR NONINVASIVE THERAPY
$905,495Riverside Research Institute · R01 · FY2003 · CA
Comparative Biomedical Scientist Training Program
$905,452Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2013 · CA
Biomarker Prediction of Gleason Upgrading
$905,451Bruce J Trock · Johns Hopkins University · RC2 · FY2009 · CA
A FIRST IN HUMAN, PHASE I CLINICAL TRIAL OF MITOCHONDRIAL-TARGETED HSP90 INHIBITOR, GAMITRINIB IN ADVANCED AND METASTATIC PROSTATE CANCER
$905,449The Wistar Institute Of Anatomy And Biology · · FY2018 · Department of the Army
Synthesis of Antiinfective Agents
$904,868Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
CELL SIGNALING IN PROSTATE CANCER PROGRESSION
$904,578University Of Virginia Charlottesville · P01 · FY2002 · CA
HSP90 and HSP70 Chaperone Proteins and Interactors in Cellular Signal Transduction
$904,298Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
CIP Genomics Core
$904,241Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC)
$903,852Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2025 · CA
EARLY DETECTION OF CASTRATION-RESISTANT PROSTATE CANCER BY ASSESSING INTERACTIONS BETWEEN CIRCULATING TUMOR CELLS AND ACCOMPANYING IMMUNE CELLS
$903,156The University Of Texas Health Science Center At San Antonio · · FY2018 · Defense Health Agency
Clinical Development of Novel Drugs for Children with Refractory Cancers
$903,024Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Cancer Immunotherapy Clinical Trials
$902,872Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
ADIPOSE STEM CELL-BASED THERAPEUTIC TARGETING OF RESIDUAL ANDROGENS IN AFRICAN AMERICANS WITH BONE-METASTATIC PROSTATE CANCER
$902,853The Administrators Of Tulane Educational Fund · · FY2011 · Department of Defense
Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors
$902,779D. Martin Watterson · Northwestern University At Chicago · U01 · FY2013 · AG
IDENTIFYING AND REDUCING DISPARITIES IN SYMPTOM BURDEN AMONG AFRICAN AMERICAN PROSTATE CANCER SURVIVORS
$902,614H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. · · FY2020 · Defense Health Agency
(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities
$902,465Margaret M Whalen · Tennessee State University · U54 · FY2025 · CA
RECIPROCAL CROSS TALK BETWEEN NOTCH SIGNALING AND HIPPO PATHWAY IN THE TUMOR MICROENVIRONMENT MEDIATES CASTRATE RESISTANT PROSTATE CANCER
$901,999Texas Tech University Health Sciences Center · · FY2017 · Department of the Army
MS/AL Radiation Oncology Research Partnership
$901,953Singing River Health System · U56 · FY2003 · CA
GWAS Studies
$901,889Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
Stromal Regulation of Bone Metastasis
$901,885Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U54 · FY2013 · CA